Voriconazole
Published date: 2018-07-17 11:53:19
|
Name | Voriconazole | CAS# | 137234-62-9 |
|---|---|---|---|---|
| Price | $Inquiry/1kg | Purity | 99.9% | |
| Stocking Period |
Inquiry | Stock | In Stock |
| Detail
Product Information
Names [ Name ]: voriconazole [ Synonym ]: More Synonyms Chemical & Physical Properties [ Density ]: 1.4±0.1 g/cm3 [ Boiling Point ]: 508.6±60.0 °C at 760 mmHg [ Melting Point ]: 127-130°C [ Molecular Formula ]: C16H14Cl2F3N5O [ Molecular Weight ]: 420.216 [ Flash Point ]: 261.4±32.9 °C [ Exact Mass ]: 419.052765 [ PSA ]: 76.72000 [ LogP ]: 0.93 [ Vapour Pressure ]: 0.0±1.4 mmHg at 25°C [ Index of Refraction ]: 1.617 MSDS Voriconazole MSDS(Chinese) Safety Information [ Symbol ]: GHS02 GHS06 GHS08 GHS02, GHS06, GHS08 [ Signal Word ]: Danger
[ Hazard Statements ]: H225-H301 + H311 + H331-H370 [ Precautionary Statements ]: P210-P260-P280-P301 + P310-P311 [ Hazard Codes ]: Xn: Harmful; [ Risk Phrases ]: R22;R36/38 [ Safety Phrases ]: S26-S36/37/39 [ RIDADR ]: UN 2811 6.1/PG 3 [ RTECS ]: UV9145000 [ HS Code ]: 2933990090 Synthetic RoutePrevious 1/6 Next (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (1R)-10-camphorsulfonate 188416-34-4 (2R,3S)-2-(2,4-... ~94% Voriconazole 137234-62-9 Voriconazole Literature: DONGKOOK PHARMACEUTICAL CO., LTD.; KWON, Hyuk Chul; RHO, Man Dong; CHA, Kyung Hoi Patent: WO2011/96697 A2, 2011 ; Location in patent: Page/Page column 14-15 ; (2R,3S)-2-(2,4-diflurophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1yl)butan-2-ol R-(-)-10-camphor sulphonate salt 848469-32-9 (2R,3S)-2-(2,4-... ~74% Voriconazole 137234-62-9 Voriconazole Literature: DR. REDDY'S LABORATORIES LTD.; DR. REDDY'S LABORATORIES, INC. Patent: WO2006/65726 A2, 2006 ; Location in patent: Page/Page column 19-20 ; 2-(2,4difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)-butan-2-ol-R(-)-10-camphor sulphonate 321589-01-9 2-(2,4difluorop... ~% Voriconazole 137234-62-9 Voriconazole Literature: WO2007/13096 A1, ; Page/Page column 10 ; Precursor & DownStream Precursor 9 Previous 1/3 Next (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (1R)-10-camphorsulfonate Structure CAS#:188416-34-4 (2R,3S)-2-(2,4-... (2R,3S)-2-(2,4-diflurophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1yl)butan-2-ol R-(-)-10-camphor sulphonate salt Structure CAS#:848469-32-9 (2R,3S)-2-(2,4-... 2-(2,4difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)-butan-2-ol-R(-)-10-camphor sulphonate Structure CAS#:321589-01-9 2-(2,4difluorop... 4-Chloro-2-methylsulfanyl-pyrimidine-5-carbonitrile Structure CAS#:137234-74-3 4-Chloro-2-meth... DownStream 0 Customs [ HS Code ]: 2933990090 [ Summary ]: 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% Articles75More Articles Antifungal susceptibility and virulence attributes of animal-derived isolates of Candida parapsilosis complex. J. Med. Microbiol. 63(Pt 11) , 1568-72, (2014) This study aimed to identify strains of the Candida parapsilosis complex isolated from animals, as well as to assess their in vitro antifungal susceptibility profile and in vitro production of virulen... Detail European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 33(9) , 1623-30, (2014) In order to better understand the epidemiology of fusariosis in Europe, a survey collecting information on the clinical characteristics of the patients infected by Fusarium as well as on the infecting... Detail Simultaneous determination of seven azole antifungal drugs in serum by ultra-high pressure liquid chromatography and diode array detection. Acta Clin. Belg. 69(1) , 53-61, (2014) Azole antifungals are a group of fungistatic agents that can be administered orally or parenterally. The determination of the concentrations of these antifungals (miconazole, fluconazole, ketoconazole... Detail Synonyms 4-Pyrimidineethanol, 6-chloro-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-, (αS,βR)-, hydrochloride (1:1) Vfend (2R,3S)-2-(2,4-Difluorphenyl)-3-(5-fluorpyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (R-(R*,S*))-a-(2,4-difluorophenyl)-5-fluoro-b-methyl-a-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol (2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (2S,3R)-3-(6-Chloro-5-fluoro-4-pyrimidinyl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol hydrochloride (1:1) (2S,3R)-3-(6-Chloro-5-fluoro-4-pyrimidinyl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol hydrochloride 4-Pyrimidineethanol, α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-, (αR,βS)- (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Voriconazole (2R,3S)-2-(2,4-difluorophényl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol EINECS 200-261-5 Vorionazole MFCD00905717 (aR,bS)-a-(2,4-difluorophenyl)-5-fluoro-b-methyl-a-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol More
|